ReviewTouchREVIEWS in endocrinology2023

Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer's Disease.

Ides M Colin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.